 |
 |
|
20 January 2004 | Volume 140 Issue 2 | Pages 125-127
This statement summarizes the current U.S. Preventive Services Task Force (USPSTF) recommendations on screening for thyroid disease and updates the 1996 recommendations on this topic. The complete USPSTF recommendation statement on this topic, which includes a brief review of the supporting evidence, is available through the USPSTF Web site (http://www.preventiveservices.ahrq.gov), the National Guideline Clearinghouse (http://www.guideline.gov), and in print through the Agency for Healthcare Research and Quality Publications Clearinghouse (telephone, 800-358-9295; e-mail, ahrqpubs.gov). The complete information on which this statement is based, including evidence tables and references, is available in the accompanying article in this issue and in the summary of the evidence and systematic evidence review on the Web sites already mentioned. The recommendation statement and article are also available in print through the Agency for Healthcare Research and Quality Publications Clearinghouse.
*For a list of the members of the U.S. Preventive Services Task Force, see the Appendix.
Author and Article Information
From the U.S. Preventive Services Task Force, Agency for Healthcare Research and Quality, Rockville, Maryland.
Disclaimer: The USPSTF recommendations are independent of the U.S. government. They do not represent the views of the Agency for Healthcare Research and Quality, the U.S. Department of Health and Human Services, or the U.S. Public Health Service.
Requests for Single Reprints: Reprints are available from the USPSTF Web site (http://www.preventiveservices.ahrq.gov) and in print through the Agency for Healthcare Research and Quality Publications Clearinghouse (800-358-9295). CLINICAL GUIDELINES
Screening for Thyroid Disease: Recommendation Statement
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  B. Vaidya and S. H S Pearce Management of hypothyroidism in adults BMJ, July 28, 2008; 337(jul28_1): a801 - a801. [Full Text]
|
|
|
|
 |
|
 J. Laukkarinen, G. Kiudelis, M. Lempinen, S. Raty, H. Pelli, J. Sand, E. Kemppainen, C. Haglund, and I. Nordback Increased Prevalence of Subclinical Hypothyroidism in Common Bile Duct Stone Patients J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4260 - 4264. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Johnson Diabetes Control in Thyroid Disease Diabetes Spectr, July 1, 2006; 19(3): 148 - 153. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Cappola, L. P. Fried, A. M. Arnold, M. D. Danese, L. H. Kuller, G. L. Burke, R. P. Tracy, and P. W. Ladenson Thyroid Status, Cardiovascular Risk, and Mortality in Older Adults JAMA, March 1, 2006; 295(9): 1033 - 1041. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Wartofsky and R. A Dickey The Evidence for a Narrower Thyrotropin Reference Range Is Compelling J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5483 - 5488. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Gharib, R. M. Tuttle, H. J. Baskin, L. H. Fish, P. A. Singer, and M. T. McDermott Subclinical Thyroid Dysfunction: A Joint Statement on Management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 581 - 585. [Full Text] [PDF]
|
|
|
|
|
|
M. I. Surks, N. F. Col, N. J. Weissman, and G. H. Daniels Screening and Treatment for Subclinical Thyroid Disease--Reply JAMA, April 7, 2004; 291(13): 1562 - 1563. [Full Text] [PDF]
|
|
|
|
 |
|
 Screening and Treatment for Thyroid Disease: Insufficient Evidence Journal Watch Gastroenterology, March 30, 2004; 2004(330): 7 - 7. [Full Text]
|
|
|
|
 |
|
 Screening and Treatment for Thyroid Disease: Insufficient Evidence Journal Watch (General), February 17, 2004; 2004(217): 2 - 2. [Full Text]
|
|
Article
